Tag: SIEN

CVNA Calls to the Moon, 6 New Ideas

Options Runners From Thursday:

We fared quite well during yesterday’s session with regard to the options ideas we formulated for our daily premarket report. Out of five potential targets, four produced sizable moves in a positive direction on the day. Four out of five isn’t bad at all, especially when one of those produced runs that blew right past the 1000% mark like it was standing still!

Those incredible, mammoth runners came from our targets in the Carvana chain, the CVNA Weekly $18.50-19.50 Calls , and the other ideas in question were the SIG Weekly $64-62 Puts, the SMAR 06/16 $40 Puts, and the GME Weekly $21.50-20.50 Puts. All three of those plays returned multi-bag gain chances of their own, and here’s how all of that played out for us:

CVNA Weekly $18.50-19.50 Calls
$18.50: .58-7.50 (+1193%)
$19: .43-7.15 (+1562%)
$19.50: .36-6.55 (+1719%)
_____

SIG Weekly $64-62 Puts
$64: 1.25-2.50 (+100%)
$63: .82-1.65 (+101%)
$62: .40-1.20 (+200%)
_____

SMAR 06/16 $40 Puts
$40: .85-2.25 (+165%)
_____

GME Weekly $21.50-20.50 Puts
$21.50: .45-1.14 (+153%)
$21: .32-.77 (+141%)
$20.50: .17-.48 (+182%)

Fresh Options Ideas:
SPY 06/09 $429 Calls*
DOCU Weekly $61-63 Calls*
TSLA Weekly $245-250 Calls*
CVNA Weekly $24.50-25.50 Calls*
BRZE 06/16 $35-40 Calls
DQ 07/21 $40-45 Calls

*Trading contracts on their day of expiration should only be attempted by experienced options traders! 

Extended Watchlist: 
SNOA, SIEN, AHI, TOI, CFRX, LEAS, VENG, SHMP, OZSC

Blue Horseshoe Stocks: Options Review & More

Apple, Inc. AAPL

We began tracking some options ideas for AAPL on Tuesday morning when we slated the AAPL 06/01 $167.50 & $170 Calls for observation. Then yesterday, we followed up with another set of ideas based on the performance of the stock, signaling the AAPL Weekly $172.50 & $175 Calls. We’re happy to report that all four of the ideas we put forth for the Apple options chain have yielded excellent chances for quick strike profits.

Beginning with the 6/01 $167.50 & $170 Calls – The $167.50’s traded up from 4.36 to hit 10.85, a rise of 149%, and the $170’s have run from 3.30-8.80 for a 167% swing.

As for our followup additions from yesterday morning, the Weekly $172.50 & $175 Calls we were very pleased with the single-session moves made by those as well. The $172.50’s ran from 2.08-3.26 (+57%) , and the $175’s went from 2.37-5.45 (+130%).

______

Mastercard, Inc. MA 

We also want to follow up with the other fresh options idea we placed in yesterday’s report, the MA Weekly $182.50-187.50 Calls, which all also posted some excellent multi-bag intraday gain chances.

$382.50 Calls – Range: 2.20-5.66 – Max Gain: 157%
$385 Calls – Range: 1.00-3.53 – Max Gain: 253%
$382.50 Calls – Range: .26-1.69 – Max Gain: 550%
______

Fresh Idea: TSLA Weekly $285-277.50 Puts

Beyond Commerce, Inc. BYOC

We like the setup of the current chart on BYOC, so we wanted to include this one as well. Its setup is currently sporting several key indicators that we always look for, and have also pointed out on the chart below.

We’ll put the stock on watch in coming sessions; with a break past the current 50DMA of .10, things could get interesting. We noted the prior resistance around .16, which would represent a nice gain from current levels if the stock were to return there.

________

Eleven Biotherapeutics, Inc. EBIO

To round things off with another successful stock call we made recently, we have EBIO, which we initially alerted on April 23rd at 1.86. Yesterday, after its fourth straight bullish session, EBIO hit 3.50, marking a move of 88% in just eight trading days.

Extended Watchlist:
SIEN, HCC, YRCW, IMTE, MYSZ, DATA, CZR

Blue Horseshoe Stocks: XXII Update & More

22nd Century Group, Inc. XXII

It was back on November 7th that we highlighted a large group of cannabis stocks, and professed our unyielding interest in the space as a whole. XXII was among those that we specifically highlighted as promising pot stocks in that report, and despite it being more than 8 weeks later, the stock has continually bulled its ways to new highs ever since.

We wanted to swing back around this morning to outline the excellent run it has been on since November. Subsequent to our report on the 7th the stock saw an absolute bottom of 2.00 even before beginning its months-long ascent. Yesterday the stock reached yet another new high of 3.85, marking an overall upswing of 93%

Yield10 Bioscience, Inc. YTEN

Following a huge single session run in early December, YTEN was unable to hold onto any of the ground it had gained, and with the ‘help’ of a massive public offering, continued to descend until recently.

This week, the stock has begun to show signs of a bottom bounce, and we’re going to want to add it to the radar on a recovery watch. As you can see form the chart snapshot included below, there is a lot of room for a potential surge, including a gap to fill to the upside.

Extended Watchlist:
NVAX, RKDA, SDRL, CRBP, SQ, CHFS, NBEV, SIEN, CNET